National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population

Nephrology Dialysis Transplantation

Volumn 22, Issue 6, 2007, Pages 1680-1684

  Hutchison, Colin A ^a,b   Dasgupta, Indranil ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Complications; Haemodialysis; Haemodialysis patients; Heparin; Heparin induced thrombocytopenia; Thrombocytopenia

Indexed keywords

ARGATROBAN; DANAPAROID; HEPARIN; HIRUDIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN; SODIUM CHLORIDE; TINZAPARIN; WARFARIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HEALTH SURVEYS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; SYNDROME; THROMBOCYTOPENIA;

EID: 34447556034     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm055     Document Type: Article

References (17)

1. Aster RH. Heparin-Induced Thrombocytopenia and Thrombosis. N Engl J Med 1995; 332: 1374-1376
2. Haase M, Bellomo R, Rocktaeschel T et al. Use of fondaparinux (ARIXTRA(R)) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. Nephrol Dial Transplant 2005; 20: 444-446
3. Aster RH. Drug-induced immune thrombocytopenia: An overview of pathogenesis. Semin Hematol 2005; 36 [1 Suppl 1]: 2-6
4. Mattioli A. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine. Semin Thromb Hemost 2004; 30: 291-295
5. Keeling D. Davidson S, Watson H. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The management of heparin-induced thrombocytopenia. Br J Haematol 2006; 133: 259-269
6. Chang JJL, Parikh CR. When heparin causes thrombosis: Significance, recognition and management of heparin induced thrombocytopenia in dialysis patients. Semin Dialysis 2006; 19: 297-304
7. Yamamoto S. Heparin-Induced Thrombocytopenia in Haemodialysis Patients. Am J Kidney Dis 1996; 28: 82-85
8. Samuelsson O, Amiral J, Attman PO et al. Heparin-induced thrombocytopenia during continuous haemofiltration. Nephrol Dial Transplant 2005; 10: 1768-1771
9. Ansell D, Feest T, Rao R, Williams A, Winearls C. The Eighth Annual Report. UK Renal Registry, December 2005.
10. Warkentin TE, Levine MN, Hirsh J et al. Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin. N Engl J Med 1995; 332: 1330-1336
11. Martel N. Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005; 106: 2710-2715
12. Palomo I, Pereira J, Alarcon M et al. Prevalence of heparin-induced antibodies in patients with chronic renal failure under-going hemodialysis. J Clin Lab Anal 2005; 19: 189-195
13. Ward D. The approach to anticoagulation in patients treated with extracorpeal. therapy in the intensive care unit. Adv Ren Replace Ther 1997; 4: 160-173
14. Pena de la Vega L, Miller RS, Benda MM. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: A population-based study. Mayo Clin Proc 2005; 80: 995-1000
15. Nakamoto H, Shimada Y, Kanno T et al. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis. Hemodial Int 2005, 9 [Suppl 1]: S2-S7
16. Mureebe L, Coats RD, Silliman WR, Shuster TA, Nichols WK. Silver D. Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients. Surgery 2004; 136:848-853
17. Arepally GM, Ortel TL. Heparin induced thrombocytopenia. N Engl J Med 2006; 355: 809-817